Status:
COMPLETED
Reactive Doses and Times During Oral Food Challenge to Peanut
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Peanut Allergy
Eligibility:
All Genders
2+ years
Brief Summary
Peanut allergy is a growing public health problem in developed countries with more and more hospitalizations for anaphylaxis. It has been determined that sensitization to certain peanut proteins such ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients with a clinical suspicion of peanut allergy who underwent OFC to peanut
- Patients not objecting to participate in the study
- Men and women are included
- Exclusion criteria:
- • The patient refused to participate in the study
Exclusion
Key Trial Info
Start Date :
October 10 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 20 2019
Estimated Enrollment :
262 Patients enrolled
Trial Details
Trial ID
NCT03852342
Start Date
October 10 2018
End Date
March 20 2019
Last Update
April 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University hospital of Montpellier
Montpellier, France, 34295